| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0925-4927(97)00012-7 |
| P698 | PubMed publication ID | 9255858 |
| P2093 | author name string | Kushner M | |
| Sakuma M | |||
| DeLisi LE | |||
| Hoff AL | |||
| Grimson R | |||
| Tew W | |||
| P2860 | cites work | Cerebral ventricular size and cognitive impairment in chronic schizophrenia | Q28263146 |
| Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? | Q28279719 | ||
| Implications of normal brain development for the pathogenesis of schizophrenia | Q29618740 | ||
| Temporal lobe asymmetries as the key to the etiology of schizophrenia | Q34293171 | ||
| Reduction of cortical volume in schizophrenia on magnetic resonance imaging | Q34344327 | ||
| Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study. | Q36418220 | ||
| Anomalous cerebral asymmetry and language processing in schizophrenia | Q36862868 | ||
| Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study | Q41161557 | ||
| Is schizophrenia a lifetime disorder of brain plasticity, growth and aging? | Q41376152 | ||
| Gliosis in schizophrenia: a survey | Q41875189 | ||
| Sylvian fissure morphology and asymmetry in men and women: bilateral differences in relation to handedness in men. | Q42086257 | ||
| 14. Brain volume loss in schizophrenia: When does it occur and is it progressive? | Q44198293 | ||
| Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study | Q44252090 | ||
| The timing of brain morphological changes in schizophrenia and their relationship to clinical outcome | Q44619595 | ||
| Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder | Q45297275 | ||
| The prediction of outcome in schizophrenia. II. Relationships between predictor and outcome variables: a report from the WHO international pilot study of schizophrenia | Q46560148 | ||
| Stability of cerebral ventricular size from the appearance of the first psychotic symptoms to the later diagnosis of schizophrenia | Q47373664 | ||
| Gender differences in corpus callosum size in first-episode schizophrenics | Q47373672 | ||
| Stability of ventricular size after the onset of psychosis in schizophrenia | Q47430377 | ||
| Decreased regional cortical gray matter volume in schizophrenia | Q48109683 | ||
| Cerebral ventricular enlargement in schizophrenia. A preliminary follow-up study | Q48379715 | ||
| Anatomical asymmetries and functional laterality | Q48495136 | ||
| Widespread cerebral gray matter volume deficits in schizophrenia | Q48515822 | ||
| Anomalous Lateral Sulcus Asymmetry and Cognitive Function in First-episode Schizophrenia | Q48558950 | ||
| 15. Follow up MRI study in first episode schizophrenia | Q48647977 | ||
| Cortical gray matter volume deficit in patients with first-episode schizophrenia | Q48854569 | ||
| Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia | Q48868128 | ||
| Pneumoencephalographic evidence of brain atrophy in acute and chronic schizophrenic patients | Q48874516 | ||
| Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia | Q49025744 | ||
| The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance | Q52112284 | ||
| Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. | Q53187821 | ||
| ENCEPHALOGRAPHIC STUDIES IN MENTAL DISEASE | Q56059695 | ||
| Ventricle-to-brain ratio in schizophrenia: a controlled follow-up study | Q60642728 | ||
| Schizophrenia: evidence of a subgroup with reversed cerebral asymmetry | Q66954256 | ||
| Progressive ventricular enlargement in schizophrenia: comparison to bipolar affective disorder and correlation with clinical course | Q68706609 | ||
| A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings | Q70862901 | ||
| Gray matter deficits in young onset schizophrenia are independent of age of onset | Q71467175 | ||
| Fibrin degradation products in post mortem brain tissue of schizophrenics: a possible marker for underlying inflammatory processes | Q71493287 | ||
| Cerebral ventricular enlargement in schizophreniform disorder does not progress. A seven year follow-up study | Q72638319 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 129-140 | |
| P577 | publication date | 1997-07-01 | |
| P1433 | published in | Psychiatry Research | Q15750888 |
| P1476 | title | Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia | |
| P478 | volume | 74 |
| Q94348002 | Q94348002 |
| Q47605592 | 30 Years on: How the Neurodevelopmental Hypothesis of Schizophrenia Morphed Into the Developmental Risk Factor Model of Psychosis |
| Q36550955 | A comprehensive testing protocol for MRI neuroanatomical segmentation techniques: Evaluation of a novel lateral ventricle segmentation method |
| Q28539784 | A longitudinal study of alterations of hippocampal volumes and serum BDNF levels in association to atypical antipsychotics in a sample of first-episode patients with schizophrenia |
| Q48752276 | A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia. |
| Q37419760 | A prospective longitudinal volumetric MRI study of superior temporal gyrus gray matter and amygdala-hippocampal complex in chronic schizophrenia |
| Q24657354 | A review of MRI findings in schizophrenia |
| Q48913191 | A serial longitudinal quantitative MRI study of cerebral changes in first-episode schizophrenia using image segmentation and subvoxel registration. |
| Q33525203 | A systematic review of the effects of antipsychotic drugs on brain volume |
| Q37327075 | Abnormal expression of myelination genes and alterations in white matter fractional anisotropy following prenatal viral influenza infection at E16 in mice |
| Q54380214 | Age and neuropsychologic function in schizophrenia: a decline in executive abilities beyond that observed in healthy volunteers. |
| Q48097590 | Age-Related Changes in Topological Degradation of White Matter Networks and Gene Expression in Chronic Schizophrenia |
| Q36304321 | Alterations in brain structures underlying language function in young adults at high familial risk for schizophrenia |
| Q33772253 | An automated method to analyze language use in patients with schizophrenia and their first-degree relatives |
| Q92523805 | Analysis of the superior temporal gyrus as a possible biomarker in schizophrenia using voxel-based morphometry of the brain magnetic resonance imaging: a comprehensive review |
| Q48300727 | Anterior cingulate activation in antipsychotic-naïve first-episode schizophrenia |
| Q34659096 | Antipsychotic drugs for first-episode schizophrenia: a comparative review |
| Q30386608 | Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection |
| Q34706991 | Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia |
| Q44400986 | Association study between glutathione S-transferase P1 polymorphism and schizophrenia in the Korean population |
| Q48497333 | Atypical psychotic symptoms and Dandy-Walker variant. |
| Q46694933 | Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study |
| Q48472081 | Brain abnormalities in schizophrenia. A qualitative comparative study of schizophrenic patients and control individuals assessed by magnetic resonance imaging |
| Q73924945 | Brain and ventricle instability during psychotic episodes of the schizophrenias |
| Q33592537 | Brain pathology in first-episode psychosis: magnetization transfer imaging provides additional information to MRI measurements of volume loss |
| Q48886754 | Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia |
| Q48188142 | Brain volumes as predictor of outcome in recent-onset schizophrenia: a multi-center MRI study |
| Q48330530 | CSF N-CAM in neuroleptic-naïve first-episode patients with schizophrenia |
| Q35821045 | CSF sub-compartments in relation to plasma osmolality in healthy controls and in patients with first episode schizophrenia |
| Q48188134 | Caudate and putamen volumes in good and poor outcome patients with schizophrenia |
| Q33612583 | Cavum septi pellucidi in first-episode schizophrenia and first-episode affective psychosis: an MRI study |
| Q30559430 | Cell biology of the hippocampal formation in schizophrenia |
| Q48655929 | Cerebellar blood volume in bipolar patients correlates with medication |
| Q48303110 | Cerebellar morphology as a predictor of symptom and psychosocial outcome in schizophrenia |
| Q30586966 | Cerebellar vermis area in schizophrenic patients - a post-mortem study |
| Q33373705 | Cerebellum and psychiatric disorders |
| Q31059838 | Cerebral atrophy and white matter disruption in chronic schizophrenia. |
| Q73924949 | Cerebral ventricular enlargement as a generalized feature of schizophrenia: a distribution analysis on 502 subjects |
| Q30958760 | Changes in brain structure caused by neuroleptic medication |
| Q41743471 | Child and adolescent schizophrenia |
| Q48383343 | Childhood onset schizophrenia: cortical brain abnormalities as young adults |
| Q33721607 | Childhood onset schizophrenia: support for a progressive neurodevelopmental disorder |
| Q48099399 | Childhood-onset schizophrenia: progressive brain changes during adolescence |
| Q42450629 | Chronic schizophrenia as a brain misconnection syndrome: a white matter voxel-based morphometry study |
| Q33745701 | Cognitive and functional changes with aging in schizophrenia |
| Q35511358 | Cognitive correlates of gray matter abnormalities in adolescent siblings of patients with childhood-onset schizophrenia |
| Q77812465 | Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients |
| Q34465783 | Cognitive impairment in elderly patients with schizophrenia: age related changes |
| Q78168649 | Convergence of cognitive and adaptive decline in late-life schizophrenia |
| Q48884454 | Corpus callosum and P300 in schizophrenia |
| Q47889709 | Corpus callosum development in childhood-onset schizophrenia |
| Q73081300 | Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia |
| Q31131636 | Cortical brain development in schizophrenia: insights from neuroimaging studies in childhood-onset schizophrenia |
| Q48865796 | Decreased functional connectivity of EEG theta-frequency activity in first-episode, neuroleptic-naïve patients with schizophrenia: preliminary results |
| Q33179819 | Defining the course of brain structural change and plasticity in schizophrenia |
| Q33745697 | Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms |
| Q43590751 | Developmental and stress-related changes of neurotrophic factor gene expression in an animal model of schizophrenia |
| Q48210470 | Differential age-related changes in the regional metencephalic volumes in humans: a 5-year follow-up |
| Q31055402 | Differential aging of the brain: patterns, cognitive correlates and modifiers |
| Q36888187 | Differential brain shrinkage over 6 months shows limited association with cognitive practice |
| Q91941858 | Diffusion abnormalities in the corpus callosum in first episode schizophrenia: Associated with enlarged lateral ventricles and symptomatology |
| Q35737237 | Direct and indirect effects of fetal irradiation on cortical gray and white matter volume in the macaque |
| Q36957729 | Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophrenia |
| Q74608840 | Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective study |
| Q46128743 | Dysequilibrium of neuronal proliferation and apoptosis in a pharmacological animal model of psychosis |
| Q46273440 | Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study |
| Q35182105 | Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences |
| Q52171892 | Early cerebro-craniofacial dysmorphogenesis in schizophrenia: a lifetime trajectory model from neurodevelopmental basis to 'neuroprogressive' process. |
| Q73574377 | Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia |
| Q43744300 | Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia. |
| Q47682586 | Emotional processing in schizophrenia across cultures: standardized measures of discrimination and experience |
| Q34023942 | Evidence for the involvement of the hippocampus in the pathophysiology of schizophrenia |
| Q33560126 | Follow-up MRI study of prefrontal volumes in first-episode psychotic patients |
| Q32161400 | Functional brain imaging and aging in schizophrenia |
| Q33662308 | GABA-ergic neurons and the neurobiology of schizophrenia and other psychoses |
| Q40227588 | Gamma oscillation deficits and the onset and early progression of schizophrenia |
| Q34415862 | Global white matter abnormalities in schizophrenia: a multisite diffusion tensor imaging study |
| Q36121482 | Gray matter volume decreases in elderly patients with schizophrenia: a voxel-based morphometry study |
| Q51979638 | Heritability of BDNF alleles and their effect on brain morphology in schizophrenia. |
| Q36390750 | Hippocampal shape and volume changes with antipsychotics in early stage psychotic illness |
| Q49022008 | Hippocampal volumetrics in treatment-resistant depression and schizophrenia: the devil's in de-tail |
| Q57725377 | Hippocampus and amygdala volumes in elderly schizophrenic patients as assessed by magnetic resonance imaging |
| Q26995247 | Hospitalization and psychosis: influences on the course of cognition and everyday functioning in people with schizophrenia |
| Q34019300 | Human brain changes across the life span: a review of 56 longitudinal magnetic resonance imaging studies |
| Q32060442 | Images of psychopathology |
| Q37320771 | Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing. |
| Q74063248 | Impact of duration of symptoms prior to first hospitalization on acute outcome in 998 schizophrenic patients |
| Q73852804 | Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia |
| Q79212686 | Increased rate of P300 latency prolongation with age in drug-naive and first episode schizophrenia |
| Q48197451 | Initial magnetic resonance imaging volumetric brain measurements and outcome in schizophrenia: a prospective longitudinal study with 5-year follow-up |
| Q33987698 | Is the cerebellum relevant in the circuitry of neuropsychiatric disorders? |
| Q43961013 | Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate |
| Q48630237 | Lack of normal structural asymmetry of the anterior cingulate gyrus in female patients with schizophrenia: a volumetric magnetic resonance imaging study |
| Q36569499 | Localized differences in caudate and hippocampal shape are associated with schizophrenia but not antipsychotic type |
| Q33814201 | Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. |
| Q36157849 | Longitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function |
| Q40718665 | Longitudinal study of brain morphology in first episode schizophrenia |
| Q30577334 | MRI anatomy of schizophrenia. |
| Q76383143 | MRI-morphometric changes in first-episode schizophrenic patients at 14 months follow-up |
| Q36024427 | Medial temporal lobe structure and cognition in individuals with schizophrenia and in their non-psychotic siblings |
| Q64446734 | Metaanálisis de estudios sobre resonancia magnética del cuerpo calloso en la esquizofrenia |
| Q96953438 | Mismatch Negativity and Impaired Social Functioning in Long-Term and in First Episode Schizophrenia Spectrum Psychosis |
| Q30250337 | Mismatch Negativity in First-Episode Schizophrenia: A Meta-Analysis |
| Q30428213 | Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment |
| Q48283679 | Negative symptoms of familial schizophrenia breed true in unstable (vs. stable) cerebral-ventricle pedigrees |
| Q37435199 | Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study |
| Q33762573 | Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage |
| Q30925033 | Neurodevelopmental hypothesis in schizophrenia |
| Q34721989 | Neurodevelopmental impairment, dopamine sensitisation, and social adversity in schizophrenia |
| Q36806465 | Neurogenesis and schizophrenia: dividing neurons in a divided mind? |
| Q35181884 | Neuroimaging communality between schizophrenia and obsessive compulsive disorder: a putative basis for schizo-obsessive disorder? |
| Q36703795 | Neuroimaging of schizophrenia: structural abnormalities and pathophysiological implications |
| Q48395659 | Neuroleptics in progressive structural brain abnormalities in psychiatric illness |
| Q91654068 | Neuroprogression across the Early Course of Psychosis |
| Q37446674 | Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models. |
| Q30988161 | Neuropsychologic functioning and structural MRI of the brain in patients with schizophrenia |
| Q46484681 | Olanzapine attenuates the okadaic acid-induced spatial memory impairment and hippocampal cell death in rats |
| Q51943076 | Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. |
| Q48884439 | P300 amplitude as a possible correlate of frontal degeneration in schizophrenia |
| Q41723380 | P300 reduction and prolongation with illness duration in schizophrenia |
| Q57411405 | P300 subcomponents and clinical symptoms in schizophrenia |
| Q102221204 | Parahippocampal area three gray matter is reduced in first-episode schizophrenia spectrum: Discovery and replication samples |
| Q34188727 | Perigenual cingulate gyrus volume in patients with schizophrenia: a magnetic resonance imaging study |
| Q48711197 | Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome |
| Q47836162 | Playing Super Mario induces structural brain plasticity: gray matter changes resulting from training with a commercial video game |
| Q34992884 | Poor outcome in chronic schizophrenia is associated with progressive loss of volume of the putamen |
| Q36606052 | Possible mechanisms of neurodegeneration in schizophrenia. |
| Q37478385 | Prefrontal cortical thickness in first-episode psychosis: a magnetic resonance imaging study |
| Q83223554 | Prevalence of movement disorders in adolescent patients with schizophrenia and in relationship to predominantly atypical antipsychotic treatment |
| Q36508050 | Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia |
| Q33798728 | Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depression |
| Q35621468 | Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic Disorders |
| Q30480517 | Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia |
| Q36395044 | Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia |
| Q33983993 | Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study |
| Q33754399 | Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia |
| Q51737156 | Prolongation of P300 latency is associated with the duration of illness in male schizophrenia patients. |
| Q46840294 | Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia |
| Q33570541 | Reduced context effects on retrieval in first-episode schizophrenia |
| Q33813149 | Regional brain volume change over the life-time course of schizophrenia |
| Q34337272 | Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study. |
| Q51966487 | Relationship of the factor structure of psychopathology in schizophrenia to the timing of initial intervention with antipsychotics. |
| Q48379900 | Relevance of brain imaging studies for social psychiatry. |
| Q47780020 | Right-hemisphere encephalopathy in elderly subjects with schizophrenia: evidence from neuropsychological and brain imaging studies |
| Q48315205 | Rightward cerebral asymmetry in subtypes of schizophrenia according to Leonhard's classification and to DSM-IV: a structural MRI study |
| Q50555595 | Risk of idiopathic normal pressure hydrocephalus in older inpatients with schizophrenia. |
| Q34268457 | Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents. |
| Q37617271 | Schizophrenia-like psychosis and dandy-walker variant comorbidity: case report |
| Q34176902 | Selection of reference gene expression in a schizophrenia brain cohort |
| Q48630239 | Selective reduction of the posterior superior vermis in men with chronic schizophrenia |
| Q48188183 | Sex-dependent effects of schizophrenia: an MRI study of gyral folding, and cortical and white matter volume. |
| Q39727461 | Statistical epistasis and progressive brain change in schizophrenia: an approach for examining the relationships between multiple genes. |
| Q34393431 | Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis |
| Q30621235 | Structural brain imaging and the prevention of schizophrenia: can we identify neuroanatomical markers for young people at risk for the development of schizophrenia? |
| Q32067082 | Structural brain imaging in schizophrenia |
| Q48886739 | Structural magnetic imaging of the hippocampus in early onset schizophrenia |
| Q38812229 | Structural neuroimaging across early-stage psychosis: Aberrations in neurobiological trajectories and implications for the staging model. |
| Q31149161 | Structural neuroimaging of the basal ganglia in schizophrenic patients: a review |
| Q37914375 | Synapsin III: role in neuronal plasticity and disease |
| Q48526279 | Temporal lobe volume changes in people at high risk of schizophrenia with psychotic symptoms. |
| Q48962151 | Ten year progressive ventricular enlargement in schizophrenia: an MRI morphometrical study |
| Q34279073 | The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions |
| Q57403374 | The Maudsley early onset schizophrenia study: cognitive function in adolescents with recent onset schizophrenia |
| Q50087983 | The Study of the Antisaccade Performance and Contingent Negative Variation Characteristics in First-Episode and Chronic Schizophrenia Patients |
| Q26861757 | The cerebellum and psychiatric disorders |
| Q24643935 | The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia |
| Q34463416 | The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches |
| Q31149257 | The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia? |
| Q73435255 | The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia |
| Q38582714 | The lifetime trajectory of schizophrenia and the concept of neurodevelopment |
| Q35001321 | The long-term effects of placebo in patients with chronic schizophrenia. |
| Q24658343 | The neurodevelopmental hypothesis of schizophrenia, revisited |
| Q36034203 | The neurodevelopmental model of schizophrenia: update 2005. |
| Q36185191 | The potential role of lamotrigine in schizophrenia |
| Q37606626 | The psychoses: cluster 3 of the proposed meta-structure for DSM-V and ICD-11. |
| Q38291702 | The role of cerebellar genes in pathology of autism and schizophrenia |
| Q73553209 | The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies |
| Q36900190 | The role of white matter for the pathophysiology of schizophrenia |
| Q36585021 | The timing of neurodevelopmental abnormality in schizophrenia: an integrative review of the neuroimaging literature. |
| Q45775101 | Three-year longitudinal population-based volumetric MRI study in first-episode schizophrenia spectrum patients. |
| Q35015837 | Time-lapse mapping of cortical changes in schizophrenia with different treatments |
| Q44704688 | Treatment of rats with antipsychotic drugs: lack of an effect on brain N-acetyl aspartate levels. |
| Q38269768 | Treatment resistance and other complicating factors in the management of schizophrenia |
| Q50961098 | Tripartite relationship among P300, clinical features and brain structure in neuroleptic-naive schizophrenia. |
| Q41818539 | Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study |
| Q31038084 | Understanding structural brain changes in schizophrenia |
| Q31048455 | Use of magnetic resonance imaging in tracking the course and treatment of schizophrenia |
| Q38936884 | Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis |
| Q48457497 | Ventricular enlargement in poor-outcome schizophrenia |
| Q38831113 | Β-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review |
Search more.